
NORTH CHICAGO, Illinois — Walgreens Boots Alliance Inc (WBA.O), the owner of the Walgreens drugstore chain, reported weaker-than-expected quarterly results on Friday and gave a disappointing forecast, sending its shares down 6%.
The company said net income fell to $380 million, or $1.08 per share, in the quarter ended May 31, from $669 million, or $1.89 per share, a year earlier. Analysts on average had expected earnings of $1.10 per share, according to Refinitiv data.
Walgreens said U.S. pharmacy sales declined 3.9% due to lower sales of generic drugs and a shift in business from high-margin long-term care to lower-margin retail. Same-store sales in the U.S. fell 2.3%.
The company's shares were down 6% at $44.60 in morning trading.
Walgreens also said it expects full-year earnings to be between $4.30 and $4.45 per share, below analysts' average estimate of $4.47 per share.
The results come as Walgreens continues to face pressure from competition in the pharmacy sector, particularly from Amazon.com Inc (AMZN.O), which has been expanding its own pharmacy services.
Walgreens Chairman and Chief Executive Officer Doug McMillon said the company is "executing against our strategic priorities" but acknowledged that "the macro environment remains challenging." (Reporting by Sanjana Sastry in Boston; Editing by Will Dunham and Nick Zieminski)
崾 complains of unsatisfactory quarterly performance and lowered its outlook, causing its shares to drop 6%.
Walgreens reported a net income of $380 million, or $1.08 per share, for the quarter ended May 31, down from $669 million, or $1.89 per share, in the same period a year earlier.
The company attributed the decline to lower U.S. pharmacy sales, which fell 3.9% due to decreased sales of generic drugs and a shift from high-margin long-term care to lower-margin retail. Same-store sales in the U.S. decreased by 2.3%.
Walgreens also announced an outlook for full-year earnings between $4.30 and $4.45 per share, below the analysts' average estimate of $4.47 per share.
The company faces ongoing pressure from competitors like Amazon, which has been expanding its pharmacy services.
Walgreens Chairman and CEO Doug McMillon stated, "We are executing against our strategic priorities," but acknowledged the challenging macro environment.
Shares of Walgreens were trading down 6% at $44.60 in morning trading.
Walgreens #QuarterlyResults #EarningsReport #StockMarket #RetailPerformance
商务部就欧盟第16轮对俄制裁列单中国企业和个人事答记者问
商务部网站
日本妄图制造“一中一台” 国台办:作为负有历史罪责的国家 应慎重处理涉台问题
央视新闻客户端
中国载人登月瞄准哪些任务?
中国航天报微信公号
中美俄均投下赞成票 联合国安理会通过美国涉乌决议
央视新闻
特朗普马克龙会晤,真松弛还是暗较劲?
新华社
高校副院长被指出轨女博士生,校方通报:免职,暂停工作
南京师范大学网站
联合国安理会通过美国涉乌决议
央视新闻客户端
严打拐卖犯罪!2024年公安机关侦破拐卖现案、积案550余起
央视新闻
2025考研国家线首次全面下降,专家:实际录取分数线可能会涨
九派新闻
金价飙升掀起“淘金热”:市民实测10元“淘金沙”等同智商税
封面新闻